Tag: mRS
The modified Rankin scale as a stroke trial endpoint: important, but...
The modified Rankin scale (mRS) is something of a default clinical outcome metric in many contemporary stroke studies, but—as Eva Mistry and Paul Wechsler...
One-year TESLA and SELECT2 data favour thrombectomy in large-core stroke patients
One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated...
Missing outcome data is common and ‘does not occur at random’...
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely...
MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...
DISTAL: A landmark trial looking to elucidate endovascular treatment outcomes in...
In December 2021, University Hospital Basel (Basel, Switzerland) enrolled the first patient worldwide in the DISTAL study—a multicentre randomised controlled trial (RCT) evaluating the...
